Biblio
Export 1296 results:
Author Title Type [ Year
Filters: First Letter Of Last Name is A [Clear All Filters]
“Uncovering the Neural Bases of Cognitive and Affective Empathy Deficits in Alzheimer's Disease and the Behavioral-Variant of Frontotemporal Dementia.”, J Alzheimers Dis, vol. 53, no. 3, pp. 801-16, 2016.
, “Validation of the Spanish version of the Baylor Profound Mental Status Examination.”, J Alzheimers Dis, vol. 49, no. 1, pp. 73-8, 2016.
, “Vascular Contributions in Alzheimer's Disease-Related Neuropathological Changes: First Autopsy Evidence from a South Asian Aging Population.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1607-1618, 2016.
, “Vascular Risk Factors and Cognition in Parkinson's Disease.”, J Alzheimers Dis, vol. 51, no. 2, pp. 563-70, 2016.
, “Ventilatory Response to Hypercapnia Predicts Dementia with Lewy Bodies in Late-Onset Major Depressive Disorder.”, J Alzheimers Dis, vol. 50, no. 3, pp. 751-8, 2016.
, “Ventilatory Response to Hypercapnia Predicts Dementia with Lewy Bodies in Late-Onset Major Depressive Disorder.”, J Alzheimers Dis, vol. 50, no. 3, pp. 751-8, 2016.
, “Vitamin D, Cognition and Alzheimer's Disease: The Therapeutic Benefit is in the D-Tails.”, J Alzheimers Dis, vol. 53, no. 2, pp. 419-44, 2016.
, “What are the Most Frequently Impaired Markers of Neurodegeneration in ADNI Subjects?”, J Alzheimers Dis, vol. 51, no. 3, pp. 793-800, 2016.
, “What are the Most Frequently Impaired Markers of Neurodegeneration in ADNI Subjects?”, J Alzheimers Dis, vol. 51, no. 3, pp. 793-800, 2016.
, “White Matter Abnormalities Track Disease Progression in PSEN1 Autosomal Dominant Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 3, pp. 827-35, 2016.
, “White Matter Changes are Associated with Ventricular Expansion in Aging, Mild Cognitive Impairment, and Alzheimer's Disease.”, J Alzheimers Dis, vol. 49, no. 2, pp. 329-42, 2016.
, “Within-Individual Variability: An Index for Subtle Change in Neurocognition in Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 54, no. 1, pp. 325-35, 2016.
, “Within-Individual Variability: An Index for Subtle Change in Neurocognition in Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 54, no. 1, pp. 325-35, 2016.
, “Acute Exposure of the Mediobasal Hypothalamus to Amyloid-β25-35 Perturbs Hepatic Glucose Metabolism.”, J Alzheimers Dis, 2015.
, “Alzheimer's Disease Normative Cerebrospinal Fluid Biomarkers Validated in PET Amyloid-β Characterized Subjects from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study.”, J Alzheimers Dis, vol. 48, no. 1, pp. 175-87, 2015.
, “Amyloid-β and Tau Dynamics in Human Brain Interstitial Fluid in Patients with Suspected Normal Pressure Hydrocephalus.”, J Alzheimers Dis, 2015.
, “Analysis of the Inhibitory Elements in the p5 Peptide Fragment of the CDK5 Activator, p35, CDKR1 Protein.”, J Alzheimers Dis, 2015.
, “A Blood-Based, 7-Metabolite Signature for the Early Diagnosis of Alzheimer's Disease.”, J Alzheimers Dis, 2015.
, “Buccal Cell Cytokeratin 14 Correlates with Multiple Blood Biomarkers of Alzheimer's Disease Risk.”, J Alzheimers Dis, vol. 48, no. 2, pp. 443-52, 2015.
, “Clinical Benefits for Older Alzheimer's Disease Patients: Okayama Late Dementia Study (OLDS).”, J Alzheimers Dis, vol. 46, no. 3, pp. 687-93, 2015.
, “Cognitive Effects of Soy Isoflavones in Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 47, no. 4, pp. 1009-19, 2015.
, “Cognitive Effects of Soy Isoflavones in Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 47, no. 4, pp. 1009-19, 2015.
, “Cognitive Function and Its Relationship with Macular Pigment Optical Density and Serum Concentrations of its Constituent Carotenoids.”, J Alzheimers Dis, vol. 48, no. 1, pp. 261-77, 2015.
, “Cognitive Impairment Precedes and Predicts Functional Impairment in Mild Alzheimer's Disease.”, J Alzheimers Dis, vol. 47, no. 1, pp. 205-14, 2015.
, “Depression and Suicidal Ideation During Two Psychosocial Treatments in Older Adults with Major Depression and Dementia.”, J Alzheimers Dis, vol. 48, no. 2, pp. 453-62, 2015.
,